2.27BMarket Cap
LossP/E TTM
Key Figures
40.990Open
42.780High
1.22MVolume
LossP/E TTM
57.26P/E Dynamic
--Dividend TTM
2.28%Turnover Ratio
41.350Prev. Close
39.920Low
36.33MTurnover
LossP/E Static
8.84P/B
0.00%Div Yield TTM
-12.95%ROA
45.83052wk High
0.82Volume Ratio
-9.96MNet Profit
53.66MShares
-0.6358EPS TTM
1.14Beta
-17.96%ROE
9.21552wk Low
6.92%Amplitude
72.67%Gross Margin
2.27BMarket Cap
-3.36Reward/Risk
3.00%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
AxoGen Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 21 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 52.78.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
AxoGen Inc Highlights
StrengthsRisks
AxoGen Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
AxoGen Inc Info
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
Ticker SymbolAXGN
CompanyAxoGen Inc
CEODale (Michael Donald)
Websitehttps://www.axogeninc.com/
Shareholders
FAQs
What is the current price of AxoGen Inc (AXGN)?
The current price of AxoGen Inc (AXGN) is 42.21.
What is the symbol of AxoGen Inc?
The ticker symbol of AxoGen Inc is AXGN.
What is the 52-week high of AxoGen Inc?
The 52-week high of AxoGen Inc is 45.83.
What is the 52-week low of AxoGen Inc?
The 52-week low of AxoGen Inc is 9.21.
What is the market capitalization of AxoGen Inc?
The market capitalization of AxoGen Inc is 2.26B.
Is AxoGen Inc (AXGN) currently rated as Buy, Hold, or Sell?
According to analysts, AxoGen Inc (AXGN) has an overall rating of Buy, with a price target of 52.78.
What is the Earnings Per Share (EPS TTM) of AxoGen Inc (AXGN)?
The Earnings Per Share (EPS TTM) of AxoGen Inc (AXGN) is -0.34.
